FORMULATION OF SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEM OF BOVINE SERUM ALBUMIN USING HLB (HYDROPHILIC-LYPOPHILIC BALANCE) APPROACH by Winarti, Lina
 
Research Article 
 
Volume 27 Issue 3 (2016)  117 
Indonesian J. Pharm. Vol. 27 No. 3 : 117 – 127   
ISSN-p : 2338-9427 
DOI: 10.14499/indonesianjpharm27iss3pp117 
 
FORMULATION OF SELF-NANOEMULSIFYING DRUG DELIVERY 
SYSTEM OF BOVINE SERUM ALBUMIN USING HLB 
(HYDROPHILIC-LYPOPHILIC BALANCE) APPROACH 
 
Lina winarti1,2, Suwaldi 3, Ronny Martien1,3*, Lukman Hakim4 
 
1Postgraduate Programme, 
Faculty of Pharmacy, 
Universitas Gadjah  Mada, 
Yogyakarta 55281, 
Indonesia; 
2Dept of Pharmaceutics, 
Faculty of Pharmacy, 
University of Jember, Jember 
68121, Indonesia; 
3Dept of Pharmaceutics, 
Faculty of Pharmacy, 
Universitas Gadjah  Mada, 
Yogyakarta 55281, 
Indonesia; 
4Dept of Pharmacology and 
Clinical Pharmacy, Faculty of 
Pharmacy, Universitas 
Gadjah  Mada, Yogyakarta 
55281, Indonesia.  
 
Submitted: 12-05-2016 
Revised: 13-06-2016  
Accepted: 15-08-2016 
 
*Corresponding author 
Ronny Martien 
  
Email: 
ronnymartien@ugm.ac.id 
ABSTRACT 
Self-Nanoemulsifying Drug Delivery System (SNEDDS) has 
potential to be developed for oral protein delivery because it is 
free from water, hence preserving the stability of protein, 
protecting protein from enzymatic degradation, and enhancing 
the protein permeability in the gastrointestinal tract (GIT). 
However, protein-based SNEDDS formulation is challenging due 
to low solubility property of protein in oil, which is towards zero. 
This present study aimed to obtain the most compatible SNEDDS 
for protein using HLB approach. Bovine serum albumin (BSA) 
was used as a protein model. A number of 78 formulas with HLB 
ranging between 11 and 15 were screened to acquire stable 
SNEDDS composition without the presence of phase separation. 
Of 13 stable formulas, two were selected (F30 and F45) with HLB 
15, and then loaded with BSA. Physical characteristics of both 
formulas were then evaluated and these results suggested that 
SNEDDS with single hydrophilic surfactant (F45) and HLB 15 was 
the best formula for protein template as the stability testing 
showed that phase separation and precipitation did not appear. It 
was robust to pH and dilution with percentage of transmittance 
of 96.40±1.05% and the droplet size of 180.9nm. F45 had also 
uniform distribution of droplets size since the polydispersity index 
was less than 0.1. The zeta potential of F45 was -0.12mv with 
loading efficiency 83.57±1.77%. The emulsifying time of F45 was 
> 2min due to the formation of crystalline gel that was difficult to 
disperse. 
 
Key words: SNEDDS, BSA, hydrophllic surfactant, lypophilic surfactant, 
protein delivery 
 
INTRODUCTION 
Oral delivery system is the most 
convenient route because it can improve 
patient adherence, especially among patients 
with chronic diseases (Noha et al., 2006). 
However, the use of protein in the development 
of oral delivery system remains a challenge due 
to enzymatic degradation, acidic environment 
of the stomach, less epitelial permeability, and 
rapid clearance from gastrointestinal tract (GIT) 
(Zhang et al., 2012; Saffran et al., 1986; Fix, 
1996). This urges researchers to develop more 
on oral delivery system of protein. Some 
techniques have been tested to improve protein 
bioavailability, including the use of absorption 
enhancer (Takatsuka et al., 2006), protease 
inhibitor (Bernkop-Schnürch and Scerbe-Saiko, 
1998), encapsulation on several delivery 
systems using nanoparticles (Sonaje et al., 2009), 
microemulsion (Sharma et al., 2010), self-nano-
emulsifying drug delivery system (SNEDDS) 
(Li et al., 2014; Ma et al., 2006; Sakloetsakun et 
al., 2013), and liposom (Wu et al., 2011).  
This present research employs Bovine 
Serum Albumin (BSA) as a protein model as it 
is sufficiently stable and widely used to evaluate 
a drug delivery system (Ravi Kumar et al., 
2009). BSA is a very hydrophillic macro-
molecule with molecular weight of 66,000 DA 
(Rachmawati et al., 2008). As a protein, the 
backbone of the protein chain is highly polar 
with the amino (-NH-) group as a strong donor 
of hidrogen bonds and the carbonyl (-CO-) 
group an acceptor of hydrogen bonds. Protein 
is made of lots of amino acids joined together 
by peptide bonds. In the presence of water the 
peptide bonds can be broken by hydrolisis. On 
the other hand, SNEDDS offers an advantage 
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for protein delivery since it has no water on it 
(Chime et al., 2014; Sakloetsakun et al., 2013; 
Patel et al., 2013). Hence, protein physical and 
chemical stability can be assured.  
SNEDDS is anhydrous form of 
nanoemulsion (preconcentrated nanoemulsion) 
consisting of oil, surfactant, co-surfactant/co-
solvent and drug that forms fine oil in water 
(O/W) nanoemulsion when introduced into 
aqueous phase under mild agitation (Rao and 
Shao, 2008; Shakloetsakun, 2013). However, 
protein solubility in the oil phase is almost zero 
(Rao and Shao, 2008). Therefore, to formulate 
protein into SNEDDS, it is necessary to find 
suitable solvent for protein. Glycerine in the 
SNEDDS formula is used as co-solvent to 
increase the solubility of therapeutic agents 
(Parul et al., 2013). According to Houen (1996) 
BSA solubility in glycerine was 20mg/mL (half 
dissolved). Because of its solubility in glycerine, 
BSA can be incorporated in SNEDDS by 
dissolving first in glycerine. Another problem 
may appear because protein has relatively large 
molecular weight and glycerine is water soluble 
compound, forming less homogenous 
SNEDDS due to phase separation during 
storage. Therefore, it is important to determine 
surfactants with suitable HLB to stabilize and 
facilitate glycerine and soluble protein in 
SNEDDS.  
In this study, a mixture of surfactant 
with similar structure, Tween and Span, were 
used (Wang et al., 2009; Weerapol, 2014) to 
obtain HLB range 11 to 15. As non-ionic 
surfactants, Tween and Span offer many 
advantages over ionic surfactant including 
increased stability, formulating flexibility, and 
wider compatibility. By combining Tween and 
Span at different ratios, a wide HLB range to 
emulsify most oils can be created (Croda, 
2010). Combinations of both surfactants were 
designed to have mixed HLB > 10 in order to 
form O/W system which is easy to become 
emulsion spontaneously in aqueous media.  
Mygliol 812 was selected as oil phase. 
Mygliol 812 is a medium chain triglyceride use 
for oral and commonly is used as penetration 
enhancer, drug carrier, and solvent (Warner 
Graham Company, 2016). 
Previous work was done on SNEDDS 
formulation using BSA complexed with 
phospholipid to increase protein solubility in oil 
(Rachmawati et al., 2008). Currently, there has 
not been a report exploring the influence of 
HLB value on SNEDDS as protein template. 
Hence, the present study developed SNEDDS 
containing BSA to establish a SNEDDS system 
for protein using HLB method. Afterward the 
formulation was subsequently subjected to the 
physicochemical characterization for oral 
delivery of protein. 
 
MATERIALS AND METHODS 
BSA, Span 20, and Span 80 were 
obtained from Sigma Aldrich, Germany. 
Mygliol® 812 was purchased from Cremer Oleo 
GmbH & Co.KG. Chremophor EL 40 was a 
gift from Shanghai Terppon China. Glycerine 
and trichloro acetic acid (TCA) were from 
Merck KgaA Germany. Tween 20, Tween 80 
were from Bratachem Indonesia, and Bio-Rad 
Protein Assay was from Bio-Rad Laboratories, 
USA. 
 
Oil phase selection 
Selection of oil phase for SNEDDS 
preparation was based on our previous study 
(Winarti et al., 2016). Four oil including Mygliol 
812, oleic acid, Span 85 and Virgin coconut oil 
(VCO) were used. It was found that only 
Mygliol 812 in SNEDDS with three surfactants 
(Tween 20, Tween 80, cremophor EL 40) and 
two co-surfactants (propylene glycol and Span 
20) gave the widest nanoemulsion area in terner 
diagram. This became the main consideration 
on choosing Mygliol 812. 
 
Surfactants selection 
In SNEDDS formulation, HLB method 
can be used as a starting point to acquire good 
emulsification characteristics. More than one 
surfactant can be blended to get desirable HLB. 
Selected surfactants should have good 
miscibility with other components in SNEDDS 
formula to produce stable and homogenous 
system. Another criterion is having relatively 
low toxicity for oral administration. HLB 
method was used to predict HLB value of 
emulsion and to design mixed ratio of two or 
more surfactants to yield a system with HLB of 
>10. Tween was selected due to structure 
similarity with Span (Wang et al., 2009), while 
selection of Chremophore EL 40 was due to its  
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structure dissimilarity with Span. Chremophore 
EL 40 is polyoxyls. Therefore, in this research, 
the combination of surfactants with different 
structure in producing good self-nanoemulsion 
was also evaluated. 
 
Co-surfactants selection 
Glycerine was used as co-solvent for 
BSA and as co-surfactant. As a co-surfactant, 
altogether with surfactants, glycerine reduce 
interfacial tension to a very minimum, and even 
negative value. Therefore, glycerine was 
selected as co-solvent and co-surfactant in the 
present research. 
 
Preparation of mixed surfactant system 
used the HLB method 
The selection of surfactants was based 
on required HLB value to form O/W 
nanoemulsion, which should be greater than 10 
(Kommuru et al., 2001). Three hydrophillic 
surfactants (Tween 20, Tween 80, and 
Chremopor EL 40) were mixed with two 
hydrophobic surfactants (Span 20 and Span 80) 
to formulate six binary surfactant combinations 
with HLB ranging from 11 to 15 (Table I). 
HLBmix of each surfactant was calculated by 
using the following equation: 
 
HLBmix= fAHLBA + fBHLBB 
where HLBA and HLBB are HLB value of 
surfactant A and surfactant B; and fA and fB are 
the fraction weight of surfactant A and 
surfactant B, respectively. 
 
Construction of SNEDDS 
SNEDDS was constructed from oil, 
surfactant, and co-surfactant in suitable 
composition to form a stable isotropic  
mixture. Mygliol 812 was used as oil phase, 
Tween 20, Tween 80, Chremophor EL 40, 
Span 20, and Span 80 were the surfactants, and 
glycerine was the co-solvent or co-surfactant 
(Table II). SNEDDS was prepared by stiring 
hydrophillic and hydrophobic surfactants at 
300rpm for ten minutes. Glycerine was then 
added to the mixture and stirred for 10min.  By 
the end of preparation process, oil component 
was added drop-by-drop and stirred for 10min.  
Various surfactant-co-surfactant and oil 
ratios were used to obtain the most stable 
SNEDDS (Table III). SNEDDS with HLB 
between 11-15 were stored for 24h and they 
were observed for phase separation. The most 
stable SNEEDS formulation, which had the 
lowest surfactant composition, the highest oil 
component, and the highest HLB was selected 
as BSA template. 
Table I. Mixed surfactant Ratio at various HLB 
 
 
HLB 
Surfactant mixing ratio (weight percent) 
Tween 
20/Span 20 
Tween 
20/Span 80 
Tween 
80/Span 20 
Tween 
80/Span 80 
Chremophor® 
EL 40/Span 20 
Chremophor® 
EL 40/Span 80 
11 29.6/70.4 54.0/46.0 37.5/62.5 62.6/37.4 49.0/51.0 72.8/27.2 
12 42.0/58.0 62.1/37.9 53.1/46.9 72.0/28.0 69.4/30.6 83.7/16.3 
13 54.3/45.7 70.2/29.8 68.8/31.3 81.3/18.7 89.8/10.2 94.6/5.4 
14 66.7/33.3 78.2/21.8 84.4/15.6 90.7/9.3 N/A N/A 
15 79.0/21.0 86.3/13.7 100.0/0.0 100.0/0.0 N/A N/A 
 
N/A: not applicable HLB 
 
Table II. Characteristic of SNEDDS forming materials 
 
Component Name Chemical Name HLB value 
Oil Mygliol® 812 Capric triglyceride 15.36 
Surfactants 
Tween 20 Polyoxyethylene 20 sorbitan mono laurate 16.7 
Tween 80 Polyoxyethylene 20 sorbitan mono oleat 15 
Chremophor® EL 40 Ethoxylated Castor Oil 13.5 
Span 20 Sorbitan monolaurat 8.6 
Span 80 Sorbitan monooleat 4.3 
Co-surfactant/Co-
solvent 
Glycerine Propane-1,2,3-triol 
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Preparation of BSA-loaded SNEDDS 
BSA was dissolved in glycerine at a 
10mg/mL concentration (Houen, 1996) and 
was stirred then. Glycerine with 1mg/mL 
concentration of BSA was added into the 
surfactant mixture and then was stirred for ten 
minutes. Mygliol 812 was added drop-by-drop 
and then was stirred again for 10min. BSA-
loaded SNEDDS formulation was stored at 
4°C  for characterization on the next step. 
 
Characterization of BSA-loaded SNEDDS 
Thermodynamic Stability 
Centrifugation study  
To investigate the effect of 
centrifugation and temperature changes on the 
stability of nanoemulsion, the formulation of 
BSA-loaded SNEDDS was evaluated by using 
the thermodynamic stability tests, including the 
centrifugation study and freeze thaw cycle test. 
Deionized water was added into the 
formulation of BSA-loaded SNEDDS in a ratio 
of 1:20. The mixture was centrifuged at 
3500rpm for 30min and then was observed 
whether phase separation and precipitation 
occured (Khedekar and Mittal, 2013; Reddy and 
Sowjanya, 2015).   
Freeze Thaw Cycle 
The SNEDDS formula remaining stable 
after centifugation was tested using freeze thaw 
cycle test. The formula was diluted with 
deionized water in a ratio of 1:20 and stored at 
temperatures of -20°C and 25°C for 48h for 
each temperature. This test was performed for 
two cycles. Phase separation and precipitation 
were observed if they occured (Khedekar and 
Mittal, 2013; Reddy and Sowjanya, 2015).   
Phase separation and stability study of 
emulsions 
Each 50µL of SNEDDS formula was 
added   into   a  vial containing 5mL of doubles  
distilled water and SGF with pH of 1.2 at room 
temperature and was vortexed for one minute.  
Each emulsion was stored and observed for 24 
hours for phase separation and precipitation 
(Reddy and Sowjanya, 2015).   
Robustness to dilution 
SNEDDS was diluted 100x and 1000x 
by using distilled water, 0.1N HCl, and 
phosphate buffer pH 6.8. Nanoemulsion was 
then stored and observed for 24h for phase 
separation and precipitation (Suresh and 
Sharma, 2011; Reddy and Sowjanya, 2015). 
Visual observation of Self-emulsification 
Self-emulsifying ability of the BSA-
loaded SNEDDS formula was evaluated by 
using visual observation until homogenous 
nanoemulsion system was formed. A total of 
250µL of BSA-loaded SNEDDS formula was 
quickly dropped in a beaker glass containing 
250mL distilled water, simulated gastric fluid 
pH 1.2 and phosphate buffer pH 6.8 at 
37±0.5°C. This medium was stirred at 100rpm. 
The duration of spontaneous nanoemulsion 
formation was recorded as self-emulsifying time 
(Weerapol et al., 2014). 
Percentage of transmittance 
SNEDDS BSA formula was added into a 
vial containing 10mL of double distilled water 
at room temperature, vortexed for 1min (Reddy 
et al., 2012), and measured for its transmittance 
using visible spectrophomo-meter at λ 650nm. 
Droplet size and zeta potential 
determination 
Distilled water was added into the 
SNEDDS BSA formula in a ratio of 1:1000 in a 
test tube. It was then vortexed for one minute. 
Particle size and polydispersity index (PDI) of 
nanoemulsion was analyzed at 25oC using 
dynamic light scattering (DLS) at an angle of 
165o (Nagarsenkar, 2007).  Zeta potential was 
measured with electrophoretic light scattering 
technique using DelsaTM Nano Beckman 
Coulter. 
Calibration curve 
Drug loading efficiency of BSA in 
SNEDDS formula was defined by using BSA 
calibration curve. Five serial concentrations of 
the formula that were 12.5, 25, 50, 75, and 
100µg/mL yielded a regression equation of y = 
0.0063x + 0.0965 with r = 0.9986.  
 
Drug loading efficiency  
To prepare the measurement of drug 
loading efficiency, 0.5g of BSA SNEDDS was 
precipitated by using 2mL of 2% TCA in an 
Eppendorf tube. It was centrifuged at 
12,000rpm for 5min. Supernatant was removed 
and protein precipitate was washed three times 
using 100µL TCA and then diluted with 1mL 
of distilled water (Rachmawati and Haryadi, 
2014). Eight hundread micro liter of BSA 
solution was added with 200µL of Bradford 
reagen and was incubated for five minutes. 
Absorbance was measured using visible 
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spectrophotometer at λ 595nm. Free BSA in 
supernatant was calculated using the regression 
equation from calibration curve which made 
previously. The equation of drug loading 
efficiency was as follow:  
Drug loading efficiency = 
 
Initial BSA–free BSA 
X 100% 
Initial BSA 
 
RESULTS AND DISCUSSION 
Preparation of mixed surfactant 
Despite the oil, surfactant is a vital 
component of SNEDDS (Shahba et al., 2012). 
The properties of surfactant, such as            
HLB value in oil, viscosity, and affinity for              
oil strongly affect the process of nano-
emulsification and the size of nanoemulsion 
droplet (Makadia et al., 2013). The mixture of 
hydrophilic and hydrophobic surfactants can be 
used to form nanoemulsion with desired 
characteristics. HLB of Surfactant with < 10 is 
hydrophobic (Span) and can produce W/O 
emulsion, whereas over > 10 is hydrophilic and 
can form O/W emulsion. Surfactant 
concentration play a role in the formation of 
droplets in nanometric size (Singh, 2009). The 
bigger the ratio between hydrophilic and 
hydrophobic surfactants, the higher the HLB. 
The proper mixture of surfactants with lower 
and higher HLB may produce nanoemulsion 
that is stable even diluted with water. The 
proper mixture may also lower the interfacial 
tension to facilitate dispersion process by 
forming flexible film that is able to readily 
deform around droplet (Kommuru et al., 2001). 
A number of 78 formulas of SNEDDS 
with HLB between 11-15 using different  ratios 
of  oil,  surfactant, and co-surfactant (Table III) 
were prepared and evaluated for their stability 
after 24h of storage at room temperature. The 
most stable formula, which did not show phase 
separation, was selected as a template for BSA 
formulation.  
Thirteen stable formulas were obtained 
after 24h of storage (Table IV). Higher HLB 
value showed higher hidrophylicity affected 
reduction of curvature on oil  interface, thereby 
increasing the solubility and making the smaller 
droplets. Therefore, in this study the stable 
SNEDDS formula with  the highest HLB value 
was selected.  Moreover, the selection of the 
best formula was also  based on higher oil 
concentration to obtain protective effect to 
protein drugs, but producing nanoemulsion 
with small droplets (Patel, 2011). The selection 
of surfactant with as low as possible 
concentration could reduce the risk of toxicity 
and irritation (Hauss, 2007). From 13 stable 
formulas, two formulas, F30 and F45, were 
selected as they had the highest  HLB that 
make the emulsification process easier, the 
highest concentration of oil component, and 
the lowest concentration of surfactant. Further 
analysis was done for those two formulas.  
 
Thermodynamic stability studies 
Thermodynamic stability studies were 
performed to detect metastable formulas by 
using centrifugation and freeze thaw cycle 
methods. Together with zeta potential, 
thermodynamic stability was used to confirm 
the stability of prepared SNEDDS on the 
minimum possible time. The tests showed that 
the formula F45 remained stable after being 
centrifuged at 3,500rpm and stored at the 
temperatures of -20°C and +25°C.  Creaming 
occured after the formula F30 was centrifuged, 
but it was able to redisperse forming 
homogenous emulsion. Reversible creaming 
also happened after the formula F30 underwent 
freeze thaw cycle. 
Nanoemulsion is a system, that is 
thermodynamically stable and is produced on 
the presence of oil, surfactant, and co-
surfactant without phase separation, creaming, 
or cracking. This differentiates nanoemulsion 
and macroemulsion, which is kinetically 
unstable and may result in phase separation 
(McClements, 2012). 
The absence of precipitate after 
centrifugation showed that protein was already 
dissolved in oil phase aided by surfactants. 
Moreover, the amount of protein dissolved in 
oil can be calculated by using evaluation of 
drug loading efficiency. 
 
Phase separation and stability study of 
emulsions 
The solvent in which SNEDDS is 
formed, pH and ion affect the phase stability 
and the drug solubility (Morais et al., 2006). The 
stability of F30 and F45 formulas were studied 
using the medium of double distilled water  and 
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SGF pH 1.2 after being stored for 24h at room 
temperature. The results showed that the 
formula F45 was stable as phase separation and 
precipitation did not occur. 
 
Robustness to dilution 
F30 and F45 were subjected to dilution 
of 3 media which were distilled water, 0.1N 
HCl, and phosphate buffer with pH 6.8 in 100x 
and 1000x dilution. They were stored at room 
temperature for 24h. The volume of dilution 
varied because of the natural variation of 
gastrointestinal fluids between subjects 
particularly on the fed and fasted states. The 
successful formulation of SNEDDS depends 
on dilutability process to produce nanodroplets. 
The formula F45 did not show phase 
separation and precipitation. F45 was robust to 
dilutions with various media. No significant 
effect of pH on F45 was observed. It 
confirmed that preparation was robust to high 
dilution and variation in pH.  
 
Visual assesment of emulsification time 
Emulsification time was conducted to 
ascertain the rapidity of nanoemulsion 
formation of SNEDDS after oral 
administration (Jain et al., 2013). Self-
emulsifying time of BSA SNEDDS was 
evaluated based on the rate of dispersion in 
aqueous media with mild agitation                    
(Table 5).  F30 was emulsified more faster             
than F45. The use of Tween 80 in the F45 
possible to form crystalline gel that was difficult 
to disperse, resulting in the emulsifying time of   
>  2min.  On the other hand, F30 was readily 
dispersed, but the dispersion was turbid due to 
lypophilic Span 80.  
 
Percentage of transmittance 
The percentage of transmittance showed 
the turbidity of emulsion made from SNEDDS 
in aqueous media that was evaluated by             
using visible spectrophotometer with λ 650nm 
(Table V). 
Table III. Component ratio of SNEDDS (Rachmawati, 2008) 
 
Component 
Ratio 
1 2 3 
Surfactant-co-surfactant 8:1 7:2 7:1 
Oil 1 1 2 
 
 
Table IV. Stable SNEDDS template formulas after 24-hours of storage 
 
Formula 
code 
HLB Mixed surfactant 
Ratio 
oil:surfactant:co-surfactant/co-solvent 
F10 14 Tween 20/Span 20 1:8:1 
F13 15 Tween 20/Span 20 1:8:1 
F24 13 Tween 20/Span 80 2:7:1 
F25 14 Tween 20/Span 80 1:8:1 
F28 15 Tween 20/Span 80 1:8:1 
F30 15 Tween 20/Span 80 2:7:1 
F34 12 Tween 80/Span 20 1:8:1 
F40 14 Tween 80/Span 20 1:8:1 
F43 15 Tween 80 1:8:1 
F45 15 Tween 80 2:7:1 
F58 15 Tween 80/Span 80 1:8:1 
F64 12 Chremophor EL 40/Span 20 1:8:1 
F66 12 Chremophor EL 40/Span 20 2:7:1 
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Percent transmittance of F45 indicated 
that the formulation was transparent. The 
transparency of the system is due to the fact 
that the droplets of the dispersed phase was not 
larger than 1/4th of the wavelength of visible 
light (Shintov and Shapiro, 2004). The 
nanoemulsion scatters light and therefore 
appears transparent or translucent. F30 was 
more turbid due to the present of lypophilic 
Span 80, although its HLB value was 
comparable to F45 that was produce using 
single hydrophilic surfactant.  
 
Droplet size and zeta potential 
measurement 
After being reconstituted in distilled 
water, the droplet size of emulsion from 
SNEDDS formula was evaluated. The 
determination of particle size and zeta potential 
were only performed on F45 using Particle Size 
Analyzer since the F30 was more turbid (Table 
VI).  
The droplet size is a critical parameter of 
SNEDDS evaluation. The smaller the droplets, 
the larger the area of absorption and the faster 
the drug release. The small droplets may 
provide larger surface area that enables 
pancreatic lipase to hydrolize and promotes 
more drug release (Mueller et al., 1994). The 
mean droplet size of F45 was in the nanometer 
range. Globul size in the range of nano              
good transparency and increase surface area 
(Figure 1). The F45 also showed the narrow 
size distribution. The polydispersity value was 
< 1 in F45 formulation. Polydispersity index            
is the  standard  deviation of the average size of  
droplets that can be used as an indicator for the 
uniformity of droplet size in a formulation 
(Chudasama et al., 2011).  
The size of nanoemulsion doplet is 
affected by the ratio of oil to surfactant 
(Fernandez et al., 2004) and the ratio of 
surfactant to co-surfactant. The larger the 
particle size, the more turbid the oil globule and 
the nanoemulsion system (Larsen et al., 2013). 
Zeta potensial is measured to determine 
the surface charge of emulsion droplet. The 
charge depends on the surfactant used. Non 
ionic surfactant was selected for this study as it 
is less toxic than ionic surfactant (Patil et al., 
2004). The zeta potential of BSA nanoemulsion 
droplet was -0.12mV (Table VI) due to the 
presence of free fatty acids (Figure 2).  
 
Drug loading efficiency 
F45 showed drug loading efficiency of 
BSA SNEDDS was 83.91±1.73%. Loading 
efficiency was analyzed using Bradford method 
with the principle of the coumassie blue dye 
bounds to primarily basis and aromatic amino 
acid residues especially arginin. The bound 
form of the dye has an absorption spectrum 
maximum at 595nm. The increase of 
absorbance at 595nm was proportional with the 
amount of bound dye and the protein 
concentration in the sample.  
 
CONCLUSION 
The present study showed the results of 
SNEDDS design for BSA based on HLB value 
approach. The problem found in preliminary 
study was glycerine separation from oil phase.  
Table V. Percentage of transmittance and visual assesment of self-emulsification (n=3) 
 
Formulation 
Name 
Percentage of 
transmittance 
Self emulsification time (second) 
Double distilled water 0.1N HCL Phosphate Buffer pH 6.8 
F30 0.37±2.88 29.30±0.25 16.93±0.30 16.32±0.09 
F45 96.40±1.05 159.00±0.30 153.00±0.08 144.00±0.08 
 
Table VI. Droplet size, zeta potential and Drug loading Efficiency 
 
Formulation 
Name 
Droplet Size 
(nm) 
PDI 
Zeta Potential 
(mV) 
Drug Loading 
efficiency (%) 
F45 180.9 0.255 -0.12 83.91±1.73 
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This should be tackled to make protein can be 
dissolved in oil. Therefore, single surfactant and 
combination of surfactant with HLB of 11-15 
were used to aid water soluble glycerine 
entering into oil phase without the occurrence 
of phase separation was designed. The 
evaluation of 78 SNEDDS templates with HLB 
11-15 showed that SNEDDS formula F45 
containing single surfactant (Tween 80) was 
able to produce stable and clear SNEDDS 
preparation after being dispersed in aqueous 
media. It can be concluded that the F45 was 
the best SNEDDS formula in this study. The 
stability studies and the characterization of BSA 
SNEDDS suggested that it has potential as a 
protein carrier. 
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